Acetic acid- and phenyl-p-benzoquinone-induced overt pain-like behavior depends on spinal activation of MAP kinases, PI3K and microglia in mice

[1]  F. Cunha,et al.  Granulocyte-Colony Stimulating Factor (G-CSF) induces mechanical hyperalgesia via spinal activation of MAP kinases and PI3K in mice , 2011, Pharmacology Biochemistry and Behavior.

[2]  Z. Tanfin,et al.  MAPK14 Cooperates with MAPK3/1 to Regulate Endothelin-1-Mediated Prostaglandin Synthase 2 Induction and Survival in Leiomyoma but Not in Normal Myometrial Cells1 , 2011, Biology of reproduction.

[3]  A. Newton,et al.  Spinal Phosphinositide 3-Kinase–Akt–Mammalian Target of Rapamycin Signaling Cascades in Inflammation-Induced Hyperalgesia , 2011, The Journal of Neuroscience.

[4]  R. Burstein,et al.  Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions , 2011, PAIN®.

[5]  A. Light,et al.  Peripheral formalin injury induces 2 stages of microglial activation in the spinal cord. , 2010, The journal of pain : official journal of the American Pain Society.

[6]  G. Landreth,et al.  Genetic Targeting of ERK1 Suggests a Predominant Role for ERK2 in Murine Pain Models , 2010, The Journal of Neuroscience.

[7]  D. Tian,et al.  Effect of pre-electroacupuncture on p38 and c-Fos expression in the spinal dorsal horn of rats suffering from visceral pain. , 2010, Chinese medical journal.

[8]  Yan Yuan,et al.  Phosphatidylinositol 3-kinase mediates pain behaviors induced by activation of peripheral ephrinBs/EphBs signaling in mice , 2010, Pharmacology Biochemistry and Behavior.

[9]  L. Sorkin,et al.  Peripheral inflammation induces tumor necrosis factor dependent AMPA receptor trafficking and Akt phosphorylation in spinal cord in addition to pain behavior , 2010, PAIN®.

[10]  J. Mao,et al.  Systemic minocycline differentially influences changes in spinal microglial markers following formalin-induced nociception , 2010, Journal of Neuroimmunology.

[11]  R. Ji,et al.  Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. , 2010, Pharmacology & therapeutics.

[12]  C. Svensson,et al.  Role of spinal p38α and β MAPK in inflammatory hyperalgesia and spinal COX-2 expression , 2010, Neuroreport.

[13]  D. Cho,et al.  IL-18 downregulates collagen production in human dermal fibroblasts via the ERK pathway. , 2010, The Journal of investigative dermatology.

[14]  M. Zheng,et al.  Expression genetics identifies spinal mechanisms supporting formalin late phase behaviors , 2010, Molecular Pain.

[15]  M. Fonseca,et al.  Quercetin reduces inflammatory pain: inhibition of oxidative stress and cytokine production. , 2009, Journal of natural products.

[16]  T. Stankowich.  Behavior , 2009, The Quarterly Review of Biology.

[17]  L. Sorkin,et al.  MKK3, an upstream activator of p38, contributes to formalin phase 2 and late allodynia in mice , 2009, Neuroscience.

[18]  J. Seo,et al.  Cytokine production through PKC/p38 signaling pathways, not through JAK/STAT1 pathway, in mast cells stimulated with IFNgamma. , 2009, Cytokine.

[19]  Hui-sheng Chen,et al.  Differential roles of peripheral mitogen-activated protein kinase signal transduction pathways in bee venom-induced nociception and inflammation in conscious rats. , 2009, The journal of pain : official journal of the American Pain Society.

[20]  F. Cunha,et al.  Teleantagonism: A pharmacodynamic property of the primary nociceptive neuron , 2008, Proceedings of the National Academy of Sciences.

[21]  K. Noguchi,et al.  Interleukin-18-Mediated Microglia/Astrocyte Interaction in the Spinal Cord Enhances Neuropathic Pain Processing after Nerve Injury , 2008, The Journal of Neuroscience.

[22]  F. Liew,et al.  Role of IL-18 in overt pain-like behaviour in mice. , 2008, European journal of pharmacology.

[23]  John Grist,et al.  Phosphatidylinositol 3-Kinase Is a Key Mediator of Central Sensitization in Painful Inflammatory Conditions , 2008, The Journal of Neuroscience.

[24]  F. Liew,et al.  IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice , 2008, Proceedings of the National Academy of Sciences.

[25]  H. Cao,et al.  Evidence for suppression of electroacupuncture on spinal glial activation and behavioral hypersensitivity in a rat model of monoarthritis , 2008, Brain Research Bulletin.

[26]  Ji-Tian Xu,et al.  Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats , 2007, Experimental Neurology.

[27]  F. Cunha,et al.  Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism. , 2007, European journal of pharmacology.

[28]  M. Bähr,et al.  Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation , 2007, Neurobiology of Disease.

[29]  L. Duan,et al.  Blocking the glial function suppresses subcutaneous formalin-induced nociceptive behavior in the rat , 2007, Neuroscience Research.

[30]  F. Cunha,et al.  Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? , 2006, Pharmacology & therapeutics.

[31]  L. Duan,et al.  The lumbar spinal cord glial cells actively modulate subcutaneous formalin induced hyperalgesia in the rat , 2006, Neuroscience Research.

[32]  T. Bártfai,et al.  MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Robert W. Gereau,et al.  Acute p38-Mediated Modulation of Tetrodotoxin-Resistant Sodium Channels in Mouse Sensory Neurons by Tumor Necrosis Factor-α , 2006, The Journal of Neuroscience.

[34]  C. Svensson,et al.  Intrathecal minocycline attenuates peripheral inflammation‐induced hyperalgesia by inhibiting p38 MAPK in spinal microglia , 2005, The European journal of neuroscience.

[35]  T. Yamashita,et al.  c-Jun N-terminal kinase activation in dorsal root ganglion contributes to pain hypersensitivity. , 2005, Biochemical and biophysical research communications.

[36]  S. Ho,et al.  Inhibition of p38 mitogen‐activated protein kinase attenuates interleukin‐1β‐induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord , 2005, Journal of neurochemistry.

[37]  S. Maier,et al.  Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation , 2005, Pain.

[38]  C. Woolf,et al.  ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model , 2005, Pain.

[39]  Yi Dai,et al.  Differential activation of MAPK in injured and uninjured DRG neurons following chronic constriction injury of the sciatic nerve in rats , 2004, The European journal of neuroscience.

[40]  R. Ji,et al.  Cell Signaling and the Genesis of Neuropathic Pain , 2004, Science's STKE.

[41]  D. Clapham,et al.  Phosphatidylinositol 3-Kinase Activates ERK in Primary Sensory Neurons and Mediates Inflammatory Heat Hyperalgesia through TRPV1 Sensitization , 2004, The Journal of Neuroscience.

[42]  J. Chichorro,et al.  Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin‐induced orofacial nociception in rats , 2004, British journal of pharmacology.

[43]  N. Calcutt,et al.  Activation of p38 mitogen‐activated protein kinase in spinal microglia is a critical link in inflammation‐induced spinal pain processing , 2003, Journal of neurochemistry.

[44]  Shokei Kim,et al.  Stress and vascular responses: mitogen-activated protein kinases and activator protein-1 as promising therapeutic targets of vascular remodeling. , 2003, Journal of pharmacological sciences.

[45]  S. Maier,et al.  Spinal Glia and Proinflammatory Cytokines Mediate Mirror-Image Neuropathic Pain in Rats , 2003, The Journal of Neuroscience.

[46]  S. Kulkarni,et al.  Role of cysteinyl leukotrienes in nociceptive and inflammatory conditions in experimental animals. , 2001, European journal of pharmacology.

[47]  F. Cunha,et al.  Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. , 2000, European journal of pharmacology.

[48]  J. Vane,et al.  Nociception in cyclooxygenase isozyme-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  S. Maier,et al.  Reversal of spinal cord non-opiate analgesia by conditioned anti-analgesia in the rat , 1997, Pain.

[50]  C. Marshall,et al.  Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras-dependent activation of the JNK/SAPK mitogen-activated protein kinase pathway , 1997, Molecular and cellular biology.

[51]  A. Eschalier,et al.  A method to perform direct transcutaneous intrathecal injection in rats. , 1994, Journal of pharmacological and toxicological methods.

[52]  J. Joris,et al.  Bradykinin is increased during acute and chronic inflammation: Therapeutic implications , 1988, Clinical pharmacology and therapeutics.

[53]  S. Ferreira,et al.  Central and peripheral antialgesic action of aspirin-like drugs. , 1978, European journal of pharmacology.

[54]  D. Dubuisson,et al.  The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats , 1977, Pain.

[55]  H. Collier,et al.  The abdominal constriction response and its suppression by analgesic drugs in the mouse. , 1968, British journal of pharmacology and chemotherapy.

[56]  S. Je,et al.  Analgesic acitivity of namoxyrate (2-[4-biphenylyl] butyric acid 2-dimethylaminoethanol salt). , 1967 .

[57]  B. Yoburn,et al.  Pharmacology, Biochemistry and Behavior , 2012 .

[58]  J. Emele,et al.  Analgesic acitivity of namoxyrate (2-[4-biphenylyl] butyric acid 2-dimethylaminoethanol salt). , 1967, Archives internationales de pharmacodynamie et de therapie.